Case Series: Abscopal Benefit of Surgery in 3 Immunotherapy-Treated Patients With Unresectable Cancer
For all of the optimism that immunotherapy has engendered, the flip side is that 7/10 patients with susceptible tumor types do not respond, while in nonsusceptible tumor types the response rates are significantly lower. In contradiction of the current orthodoxy against surgery in the setting of unre...
Saved in:
Main Authors: | Bryan Oronsky MD (Author), Chris Larson MD, PhD (Author), Tony R. Reid MD, PhD (Author), Corey A. Carter MD (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2018-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Topical imiquimod and cryotherapy in combination with systemic immunotherapy in unresectable stage IIIC melanoma
by: Jennifer E. Yeh, MD, PhD, et al.
Published: (2022) -
Assessing the Influence of Subsequent Immunotherapy on Overall Survival in Patients with Unresectable Stage III Non-Small Cell Lung Cancer from the PACIFIC Study
by: Mario Ouwens, PhD, et al.
Published: (2021) -
Topical imiquimod in combination with brachytherapy for unresectable cutaneous melanoma scalp metastases
by: Jennifer E. Yeh, MD, PhD, et al.
Published: (2023) -
Primary unresectable locally invasive biatrial paraganglioma presenting with chest pain
by: Israa Laklouk, MD, et al.
Published: (2018) -
The Need to Deepen the Abscopal Effect and Synergy among Radiotherapy and Immunotherapy
by: Denaro Nerina
Published: (2018)